Pressure BioSciences, Inc. Annual report pursuant to Section 13 and 15(d)

2. Summary of Significant Accounting Policies (Details 3)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies Details 3
Stock options	3,406,250pbio_StockOptions	1,771,708pbio_StockOptions
Convertible debt	5,453,571pbio_ConvertibleDebtDilutiveSecurities	2,242,024pbio_ConvertibleDebtDilutiveSecurities
Common stock warrants	19,182,201pbio_CommonStockWarrants	15,012,327pbio_CommonStockWarrants
Convertible preferred stock:
Series D Convertible Preferred stock	750,000pbio_SeriesDConvertiblePreferred	750,000pbio_SeriesDConvertiblePreferred
Series G Convertible Preferred stock	865,700pbio_SeriesGConvertiblePreferred	1,453,200pbio_SeriesGConvertiblePreferred
Series H Convertible Preferred stock	1,000,000pbio_SeriesHConvertiblePreferred	1,000,000pbio_SeriesHConvertiblePreferred
Series H2 Convertible Preferred	2,100,000pbio_SeriesH2ConvertiblePreferred	0pbio_SeriesH2ConvertiblePreferred
Series J Convertible Preferred stock	3,546,000pbio_SeriesJConvertiblePreferred	5,087,500pbio_SeriesJConvertiblePreferred
Series K Convertible Preferred stock	11,416,000pbio_SeriesKConvertiblePreferred	4,000,000pbio_SeriesKConvertiblePreferred
Total potentially dilutive shares	47,719,722pbio_TotalPotentiallyDilutiveShares	31,316,759pbio_TotalPotentiallyDilutiveShares